GeneThera Inc. (GTHR)

[QuitinMyJob]

Hi xxxxx,

 

Thank you kindly for the congratulations! It took time, but it was all worth the efforts from all involved. I don’t know if you have noticed; but, most investors like to keep their investments private. We used to go with private investors, but after what happened to us with our previous investor, we are particularly uneasy. Another viable option for non-toxic  funding is for us to go with the government. Investors changing their minds because they had their own private agenda and/or not understanding how public biotech companies operate, it’s disturbing, but true. GeneThera’s primary focus is to improve the well-being of the public by creating the most accurate, sensitive molecular biology robotic technology, which is desperately needed by bringing positive, effective testing for vaccine development.  Possibly, filing press releases, might clarify misunderstanding, confusion and even illuminate those, who find our biotech robotic technology a mystery. Please forgive me Chris, but we are in the middle of moving. It is always nice hearing from you. After the move, we will go back on track. Take care. Be safe and stay healthy.

 

Cordially,

Tannya Irizarry, CAO, CFO (Interim)

GeneThera, Inc.

720-587-5100 Office